138 related articles for article (PubMed ID: 28197806)
1. Recruiting families at risk for hereditary breast and ovarian cancer from a statewide cancer registry: a methodological study.
Katapodi MC; Duquette D; Yang JJ; Mendelsohn-Victor K; Anderson B; Nikolaidis C; Mancewicz E; Northouse LL; Duffy S; Ronis D; Milliron KJ; Probst-Herbst N; Merajver SD; Janz NK; Copeland G; Roberts S
Cancer Causes Control; 2017 Mar; 28(3):191-201. PubMed ID: 28197806
[TBL] [Abstract][Full Text] [Related]
2. Genetic Testing and Surveillance of Young Breast Cancer Survivors and Blood Relatives: A Cluster Randomized Trial.
Katapodi MC; Ming C; Northouse LL; Duffy SA; Duquette D; Mendelsohn-Victor KE; Milliron KJ; Merajver SD; Dinov ID; Janz NK
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32899538
[TBL] [Abstract][Full Text] [Related]
3. Predictors and interdependence of family support in a random sample of long-term young breast cancer survivors and their biological relatives.
Katapodi MC; Ellis KR; Schmidt F; Nikolaidis C; Northouse LL
Cancer Med; 2018 Oct; 7(10):4980-4992. PubMed ID: 30187678
[TBL] [Abstract][Full Text] [Related]
4. Disparities in genetic services utilization in a random sample of young breast cancer survivors.
Nikolaidis C; Duquette D; Mendelsohn-Victor KE; Anderson B; Copeland G; Milliron KJ; Merajver SD; Janz NK; Northouse LL; Duffy SA; Katapodi MC
Genet Med; 2019 Jun; 21(6):1363-1370. PubMed ID: 30385886
[TBL] [Abstract][Full Text] [Related]
5. Surveillance for cancer recurrence in long-term young breast cancer survivors randomly selected from a statewide cancer registry.
Jones T; Duquette D; Underhill M; Ming C; Mendelsohn-Victor KE; Anderson B; Milliron KJ; Copeland G; Janz NK; Northouse LL; Duffy SM; Merajver SD; Katapodi MC
Breast Cancer Res Treat; 2018 May; 169(1):141-152. PubMed ID: 29353367
[TBL] [Abstract][Full Text] [Related]
6. Using a state cancer registry to recruit young breast cancer survivors and high-risk relatives: protocol of a randomized trial testing the efficacy of a targeted versus a tailored intervention to increase breast cancer screening.
Katapodi MC; Northouse LL; Schafenacker AM; Duquette D; Duffy SA; Ronis DL; Anderson B; Janz NK; McLosky J; Milliron KJ; Merajver SD; Duong LM; Copeland G
BMC Cancer; 2013 Mar; 13():97. PubMed ID: 23448100
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
Lerman C; Narod S; Schulman K; Hughes C; Gomez-Caminero A; Bonney G; Gold K; Trock B; Main D; Lynch J; Fulmore C; Snyder C; Lemon SJ; Conway T; Tonin P; Lenoir G; Lynch H
JAMA; 1996 Jun; 275(24):1885-92. PubMed ID: 8648868
[TBL] [Abstract][Full Text] [Related]
9. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
[TBL] [Abstract][Full Text] [Related]
10. Identifying Mediators of Intervention Effects Within a Randomized Controlled Trial to Motivate Cancer Genetic Risk Assessment Among Breast and Ovarian Cancer Survivors.
An J; Lu SE; McDougall J; Walters ST; Lin Y; Heidt E; Stroup A; Paddock L; Grumet S; Toppmeyer D; Kinney AY
Ann Behav Med; 2023 Oct; 57(11):965-977. PubMed ID: 37658805
[TBL] [Abstract][Full Text] [Related]
11. Psychosocial outcomes and counselee satisfaction following genetic counseling for hereditary breast and ovarian cancer: A patient-reported outcome study.
Oberguggenberger A; Sztankay M; Morscher RJ; Sperner-Unterweger B; Weber I; Hubalek M; Kemmler G; Zschocke J; Martini C; Egle D; Dünser M; Gamper E; Meraner V
J Psychosom Res; 2016 Oct; 89():39-45. PubMed ID: 27663109
[TBL] [Abstract][Full Text] [Related]
12. Online couples mindfulness-based intervention for young breast cancer survivors and their partners: A randomized-control trial.
Price-Blackshear MA; Pratscher SD; Oyler DL; Armer JM; Cheng AL; Cheng MX; Records K; Udmuangpia T; Carson JW; Ann Bettencourt B
J Psychosoc Oncol; 2020; 38(5):592-611. PubMed ID: 32552446
[TBL] [Abstract][Full Text] [Related]
13. Characteristics associated with participation at various stages at the Ontario site of the cooperative family registry for breast cancer studies.
Knight JA; Sutherland HJ; Glendon G; Boyd NF; Andrulis IL;
Ann Epidemiol; 2002 Jan; 12(1):27-33. PubMed ID: 11750237
[TBL] [Abstract][Full Text] [Related]
14. Should women at increased risk for breast and ovarian cancer be randomized to prophylactic surgery? An ethical and empirical assessment.
Tambor ES; Bernhardt BA; Geller G; Helzlsouer KJ; Doksum T; Holtzman NA
J Womens Health Gend Based Med; 2000 Apr; 9(3):223-33. PubMed ID: 10787220
[TBL] [Abstract][Full Text] [Related]
15. Examining the challenges of family recruitment to behavioral intervention trials: factors associated with participation and enrollment in a multi-state colonoscopy intervention trial.
Simmons RG; Lee YC; Stroup AM; Edwards SL; Rogers A; Johnson C; Wiggins CL; Hill DA; Cress RD; Lowery J; Walters ST; Jasperson K; Higginbotham JC; Williams MS; Burt RW; Schwartz MD; Kinney AY
Trials; 2013 Apr; 14():116. PubMed ID: 23782890
[TBL] [Abstract][Full Text] [Related]
16. Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2.
Bluman LG; Rimer BK; Berry DA; Borstelmann N; Iglehart JD; Regan K; Schildkraut J; Winer EP
J Clin Oncol; 1999 Mar; 17(3):1040-6. PubMed ID: 10071299
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
18. Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients.
Landsbergen K; Verhaak C; Kraaimaat F; Hoogerbrugge N
Fam Cancer; 2005; 4(2):115-9. PubMed ID: 15951961
[TBL] [Abstract][Full Text] [Related]
19. What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing.
Lerman C; Hughes C; Lemon SJ; Main D; Snyder C; Durham C; Narod S; Lynch HT
J Clin Oncol; 1998 May; 16(5):1650-4. PubMed ID: 9586874
[TBL] [Abstract][Full Text] [Related]
20. Predictors of Response Outcomes for Research Recruitment Through a Central Cancer Registry: Evidence From 17 Recruitment Efforts for Population-Based Studies.
Millar MM; Kinney AY; Camp NJ; Cannon-Albright LA; Hashibe M; Penson DF; Kirchhoff AC; Neklason DW; Gilsenan AW; Dieck GS; Stroup AM; Edwards SL; Bateman C; Carter ME; Sweeney C
Am J Epidemiol; 2019 May; 188(5):928-939. PubMed ID: 30689685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
